22OCT

UK chip exits hit six, a five-year low

2 min read

16:30UTC

UK semiconductor acquisitions stand at six for the year with no flotation at all, while funding into the same sector already exceeds all of last year.

← Back to Stryker agrees option to buy CMR Surgical Jump to analysis ↓

TechnologyDeveloping

Key takeaway

Chip funding is up and chip exits are at a five-year low, with robotics money concentrated in Cambridge.

UK semiconductor acquisitions stand at six for the year to date, the lowest count in a five-year series, against ten in 2025 and eighteen in 2023, with no initial public offering (IPO) at all⁠¹. Funding into the same sector runs at $321m, already ahead of the whole of last year. Robotics shows the pattern from the other end: $258m across 12 rounds in 2026 against $150m across 8 rounds in all of 2025⁠².

More capital in and fewer routes out is an arithmetic problem for investors before it is a strategic one. A venture fund with a ten-year life needs exits to return capital, and a sector where trade sales have halved and the listing window is shut pushes those returns towards the back of the fund. That pressure shows up first as longer holds, then as pressure on founders to sell to whoever is buying, which in British chip and security companies has consistently meant American acquirers.

Cambridge holds $1.3bn of cumulative robotics funding across just 12 companies, while London holds $582m across 103. One London round, Humanoid's $152m Series A in July, and one other account for roughly three quarters of the year's robotics total. A sector where two deals carry the annual figure is not yet a sector, and the same concentration ran through last year's equity data, when AI took 44% of all smaller-business equity value.

Both sets of figures come from Tracxn data reported by a single trade outlet, and the underlying report is not on Tracxn's own site. Treat the direction as sound and the decimals as second-hand.

Deep Analysis

In plain English

Two numbers show a British hardware sector that is attracting more investment but producing fewer ways for early investors to cash out. Only six UK semiconductor, computer chip, companies were bought out this year, the lowest number in five years, and none went public. Meanwhile, money going into UK chip companies has already passed $321m for the year, more than all of last year combined. $321m has already gone into the sector this year, more than any owner has managed to cash out through a sale or listing. Robotics funding jumped too: $258m across 12 rounds this year, up from $150m across 8 rounds in all of 2025. But that money is concentrated: Cambridge's 12 robotics companies have raised $1.3bn between them, an average of more than $100m each, while London's 103 robotics companies share $582m, an average of under $6m each. These figures come from data firm Tracxn, reported by a single trade outlet; the direction is reliable, the exact decimals less certain.

Deep Analysis

Root Causes

Six semiconductor acquisitions and no IPOs against $321m of fresh sector funding means capital keeps entering chip companies faster than owners can exit them; the same imbalance that pushes valuations up at the funding stage also lengthens the wait for an exit, because acquirers and public markets absorb new companies more slowly than venture funds create them.

Robotics shows the same capital concentrating geographically rather than only by company: Cambridge holds $1.3bn of cumulative robotics funding across just 12 companies, an average of over $100m each, while London holds $582m spread across 103 companies, under $6m each. One or two large London rounds account for three quarters of the year's robotics total, which means the London figure is a small number of big winners inside a much longer tail of small ones, not 103 evenly-funded companies.

What could happen next?

Risk
UK semiconductor investors face a widening gap between capital going into chip companies and available exit routes, with only six acquisitions and no IPOs this year.

Sources:UKTN·UKTN

Mentions:London →Cambridge →Humanoid →

First Reported In

Update #14 · UKRI's sponsor department no longer exists

UKTN· 24 Aug 2026

Read original →

Causes and effects

Caused by

Dealroom projects $34.2bn for UK tech

Dealroom's $34.2bn full-year projection rests on a market where semiconductor exits and robotics funding move unevenly.

Occurred 23 Jul 2026

Read story →

AI takes record 44% of UK equity market

AI's record 44% equity share last year sits behind this year's uneven semiconductor and robotics figures.

Occurred 1 Jul 2026

Read story →

This Event

UK chip exits hit six, a five-year low

More capital going into a sector with fewer ways out of it changes how long investors have to hold, and robotics shows the same money concentrating on one city.

Led to

Nscale files for New York at $14.6bn

Nscale's move to New York followed a UK listing window shut by a five-year low in semiconductor exits with no flotation.

Occurred 18 Sept 2026

Read story →

Different Perspectives

Abu Dhabi Investment Council

The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.

CDP Venture Capital

CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.

EDBI

Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.

Forbion

Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.

British Business Bank

The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.

Stryker Corporation

Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.